MedTrace Logo

Assessment of Postoperative Pain After Using Various Intracanal Medication in Patients With Necrotic Pulp

NCT03692286 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-10-19

No results posted yet for this study

Summary

To assess the Postoperative Pain after using Silver Nanoparticles with and without Calcium Hydroxide as an Intracanal Medication in Patients with necrotic pulp (RCT)

Conditions

  • Postoperative Pain

Interventions

COMBINATION_PRODUCT

Silver nanoparticle/Calcium hydroxide

Intracanal Medication composed of combined silver nanoparticles with calcium hydroxide

DRUG

Silver Nanoparticles in gel form

Intracanal medication composed of silver nanoparticles in gel form

DRUG

Calcium Hydroxide Intracanal medication

Calcium hydroxide intracanal medication

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Nermine Hassan, Msc · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-08-18
Completion
2020-09-18

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03692286 on ClinicalTrials.gov